Type I Interferon Predicts an Alternate Immune System Phenotype in Systemic Lupus Erythematosus.

We find striking differences in resting and stimulated cytokine patterns in high- vs. low-IFN SLE patients, which supports the biological importance of these patient subsets. These data could inform personalized treatment approaches and the pathogenesis of SLE flare following infection.